February 10, 2017 / 14:27 IST
Centrum's research report onFDC FDC’s Q3FY17 revenues were flat at Rs 2.31bn. As per AIOCD AWACS MAT data-December’16, FDC’s revenues declined by 2.3%, compared to market growth rate of 7.2%. The company’s nine major brands are listed among the top 1,000 brands and contributed 46% to its revenues, indicating high dependence on these brands.
Outlook
Story continues below Advertisement
We downgrade FDC to Hold from Buy rating, with a TP of Rs 220 (earlier Rs270) based on 17x March’19E EPS of Rs 13.0. FDC’s Q3FY17 results were below our expectations and were affected by demonetisation. FDC reported flat growth in revenues, 400bps decline in EBIDTA margin to 15.9% and a 32% decrease in net profit. Eight out of its top nine brands lagged market growth. Key downside risks to our assumptions are slower growth of its major brands and key upside risk is faster growth in the domestic market. We recommend a switch to Sanofi India or Granules India.
For all recommendations, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions. 
Read More
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
